Robert Lutz

Company: Iksuda Therapeutics

Job title: Chief Scientific Officer

Seminars:

Targets 101: Outlining the Current ADC Target Landscape 9:05 am

This session will allow you to gain detailed knowledge of the current antibody-drug conjugate target landscape, covering both highly saturated clinically validated targets, to more novel explorations. This will provide you with key insights to determine your next ADC target for development. Join this workshop to get an up-to-date understanding of the current target landscape,…Read more

day: Pre-Conference Workshop Day